Profile
LUCY ISRG BDX BDXA ALC RMD
Company Name Innovative Eyewear, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $4.50M $173.36B $59.94B $55.91B $39.26B $37.85B
Employees 0.01K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Harrison Reed Gross David J. Rosa Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell
Ratings
LUCY ISRG BDX BDXA ALC RMD
Quant Rating Score 2 1 3 5 3 4
Quant Rating Sell Strong Sell Neutral Strong Buy Neutral Buy
Trading
LUCY ISRG BDX BDXA ALC RMD
Last Close $1.61 $546.71 $190.98 $59.24 $76.61 $244.71
High 52 $7.4 $610.45 $249.08 $59.24 $98.3 $293.73
Low 52 $1.52 $429.59 $165.15 $59.24 $72.05 $204.58
Price vs. 52 Week High -78.24 % -10.44 % -23.33 % 0 % -22.07 % -16.69 %
Price vs. 52 Week Low 5.92 % 27.26 % 15.64 % 0 % 6.33 % 19.62 %
Total Return
LUCY ISRG BDX BDXA ALC RMD
1 Month Return -11.54 % 22.54 % 0.99 % 0 % 2 % -8.72 %
3 Month Return -20.3 % 13.64 % -2.06 % 0 % -13.07 % -14.47 %
6 Month Return -42.5 % -3 % 8.88 % 0 % -14.72 % -2.77 %
9 Month Return -65.08 % -9.02 % -15.17 % 0 % -14.35 % 6.13 %
YTD Return -67.28 % 4.74 % -15.82 % 0 % -9.75 % 7.01 %
1 Year Return -76.93 % 1.46 % -14.22 % 0 % -10.32 % 2.77 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
LUCY ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.99 % 2.02 % 0.42 % 0.87 %
Dividend Paid and Capex Coverage Ration (TTM) -77.86 % 4.3 % 1.75 % 1.75 % 3.02 % 4.31 %
Dividend Per Share (TTM) - - 4.17 % 4.17 % 0.33 % 2.26 %
Payout Ratio (TTM) - - 71.28 % 71.28 % 15.49 % 22.31 %
Growth
LUCY ISRG BDX BDXA ALC RMD
Asset Growth 58.2 % - 18.95 %
Gross Profit Growth 280.33 % 18.13 % 15.05 %
Revenue Growth 41.99 % 20.51 % 9.84 %
Revenue 3 Year -58.47 % 61.21 % 43.19 %
Revenue 5 Year 2155.92 % 127.11 % 71.22 %
Revenue 10 Year 2155.92 % 294.9 % 193.47 %
EBIT Growth -16.61 % 40.98 % 28.01 %
Net Income Growth -16.55 % 22.97 % 37.2 %
Net Income 3 Yeari Growth Per Share 58.04 % 115.26 % 78.91 %
Net Income 5 Yeari Growth Per Share -371.7 % 164.83 % 121.66 %
Net Income 10 Yeari Growth Per Share -371.7 % 353.8 % 280.03 %
Operating Income Growth -15.58 % 25.4 % 27.69 %
Operating Cash Flow Growth (CFG) -16.88 % - 25 %
Operating 3 Year CFG 2.7 % -100 % 396.61 %
Operating 5 Year CFG - -100 % 114.79 %
Operating 10 Year CFG - -100 % 337.65 %
EPS Growth 59.04 % 22.32 % 37.61 %
EPS Diluted Growth 59.04 % 22.59 % 37.43 %
Book Value Per Share -42.51 % -100 % 22.95 %
Share Holder 3 Year Equity Growth Per Share 668.23 % -100 % 76.79 %
Share Holder 5 Year Equity Growth Per Share 224.93 % -100 % 135.12 %
Share Holder 10 Year Equity Growth Per Share 224.93 % -100 % 259.96 %
Dividend Per Share Growth - - 10.35 %
Dividend 3 Year Growth Per Share - - 26.15 %
Dividend 5 Year Growth Per Share - - 35.87 %
Dividend 10 Year Growth Per Share - - 89.26 %
Debt Growth - - -2.53 %
Free Cash Flow Growth -16.43 % - 29.18 %
Updated On 31 Dec 2024 31 Dec 2025 30 Jun 2025
Profitability
LUCY ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 22.84 % 66.06 % 45.44 % 45.44 % 55.12 % 60.08 %
Return on Assets TTM -0.07 % 14.76 % 3.03 % 3.03 % 3.32 % 17.31 %
Return on Equity TTM -0.31 % 16.72 % 6.63 % 6.63 % 4.77 % 25.13 %
Return on Capital Employed TTM -0.08 % 16.78 % 5.48 % 5.48 % 5.06 % 24.74 %
Net Income Per EBT TTM 100 % 86.25 % 89.16 % 89.16 % 84.1 % 82.6 %
EBT Per Ebit TTM 96.07 % 112.42 % 73 % 73 % 86.34 % 99.79 %
EBIT Per Revenue TTM -341.41 % 29.27 % 11.8 % 11.8 % 14.16 % 33.18 %
Cash Flow To Debt Ratio TTM - - 17.88 % 17.88 % 39.18 % 222.53 %
Receivables Turnover TTM 0.03 7.27 7.29 7.29 5.26 5.49
Payables Turnover TTM - 11.73 - - 5.11 7.87
Inventory Turnover TTM - 1.92 3.06 3.06 1.88 2.22
Fixed Asset Turnover TTM 4.11 % 195.4 % 312.12 % 312.12 % 198.09 % 724.52 %
Asset Turnover TTM 0.02 % 52.01 % 39.47 % 39.47 % 32.34 % 63.28 %
Operating Cash Flow Per Share TTM -1.62 8.34 11.97 11.97 4.16 12.86
Free Cash Flow Per Share TTM -1.64 6.4 9.32 9.32 3.11 12.06
Cash Per Share TTM 137566.65 % 1383.15 % 299.71 % 299.71 % 303.41 % 944.79 %
Operating Cash Flow Sales Ratio TTM -328.87 % 29.42 % 15.71 % 15.71 % 20.13 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.28 % 76.72 % 77.84 % 77.84 % 74.75 % 93.83 %
Cash Flow Coverage Ratios TTM - - 17.88 % 17.88 % 39.18 % 222.53 %
Price To Free Cash Flows Ratio TTM -0.56 76.32 22.45 22.08 25.61 21.42
Price To Operating Cash Flows Ratio TTM -0.61 58.52 17.55 17.26 19.09 20.16
Price Cash Flow Ratio TTM -0.61 58.52 17.55 17.26 19.09 20.16
Income Statement (TTM)
LUCY ISRG BDX BDXA ALC RMD
Revenue $0B $10.06B $21.84B $21.84B
Gross Profit $0B $6.66B $9.92B $9.92B
Gross Profit Ratio 13.15% 66.13% 45.44% 45.44%
EBITDA $-0.01B $3.31B $4.96B $4.96B
Net Income $-0.01B $2.86B $1.68B $1.68B
EPS Diluted -5.19 7.87 5.83 5.83
Balance Sheet (MRQ)
LUCY ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.11B $17.62B $17.62B
Total Liabilities $0B $2.31B $29.94B $29.94B
Total Equity $0.01B $16.53B $25.39B $25.39B
Total Investments $0B $7.05B $0.01B $0.01B
Total Debt $0B $0.15B $19.18B $19.18B
Total Assets $0.01B $18.84B $55.33B $55.33B
Cash Flow Statement (TTM)
LUCY ISRG BDX BDXA ALC RMD
Net Income $-0.01B $2.34B $1.68B $1.68B
Inventory $-0B $-0.83B $-0.41B $-0.41B
Dividends Paid $0B $0B $-1.2B $-1.2B
Operating Cash Flow $-0.01B $2.42B $3.43B $3.43B
Capital Expenditure $-0B $-1.11B $-0.76B $-0.76B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.83
ANGO AngioDynamics, Inc. 10.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 134.31
ATRC AtriCure, Inc. 37.11
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.26
AZTA Azenta, Inc. 28.72
BAX Baxter International Inc. 21.73
BDX Becton, Dickinson and Company 210.02
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17
BLFS BioLife Solutions, Inc. 22.43
COO The Cooper Companies, Inc. 82.1
DXR Daxor Corporation 12.345
EKSO Ekso Bionics Holdings, Inc. 10.41
ETFs With Exposure to LUCY
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00004 217.96
DFAT Dimensional U.S. Targeted Value ETF 0.00000174 66.71
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00004 165.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00004 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0.00004 408.25
Unlock